Глава 2. Бросить курить легко?

Богданов И. Дым отечества, или Краткая история табакокурения. М.: Новое литературное обозрение, 2007. – 280 с.
http://www.who.int/tobacco/surveillance/ru_tfi_gatsrussian_countryreport.pdf – подсчет числа курильщиков от ВОЗ.
West R. et al. Smoking Cessation Guidelines for Health Professionals: an Update // Thorax. 2000. Vol. 55. P. 987–999.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a.htm – статистика CDC о желании бросить.
http://www.who.int/substance_abuse/terminology/who_lexicon/en/index.html – словарь терминов от ВОЗ.
http://www.sis.indiana.edu/DSM—IV–Criteria.aspx – кр итерии зависимости от наркотических веществ, разработанные Американской психиатрической ассоциацией.
http://base.garant.ru/12112176/#1000 – официальный перечень наркотических средств в России.
Nutt D. et al. Development of a Rational Scale to Assess the Harm of Drugs of Potential Misuse // Lancet. 24 March 2007. Vo l. 369. No. 9566. P. 1047–1053.
Graef S. et al. Cholinergic Receptor Subtypes and Their Role In Cognition, Emotion, and Vigilance Control: an Overview of Preclinical and Clinical Findings // Psychopharmacology (Berlin). May 2011. Vol. 215. No. 2. P. 205–29.
D’Souza M. S., Markou A. Neuronal Mechanisms Underlying Development of Nicotine Dependence: Implications for Novel Smoking-Cessation Treatments // Addiction Science & Clinical Practice. 6 July 2011. Vol. 6. No. 1. P. 4–16.
Olds J., Milner P. Positive Reinforcement Produced by Electrical Stimulation of Septal Area and Other Regions of Rat
Brain // Journal of Comparative and Physiological Psychology. December 1954. Vol. 47. No. 6. P. 419–427.
Bewernick B. H. et al. Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression // Biological Psychiatry. 15 January 2010. Vol. 67. No. 2. P. 110–116.<
> Diana M. The Dopamine Hypothesis of Drug Addiction and Its Potential Therapeutic Value // Front Psychiatry. 2011. Vol. 2. P. 64.
Griesar W. S. et al. Nicotine Effects on Alertness and Spatial Attention in Non-Smokers // Nicotine & Tobacco Research. May 2002. Vol. 4. No. 2. Р. 185–194.
Shah D. et al. Neural Effects of Acute Nicotinic Treatment on Visual Spatial Attention in Non-Smokers // Pharmacology, Biochemistry and Behavior. 2011. Vol. 100. P. 228–236.
Govind A. P. et al. Nicotine-Induced Upregulat ion of Nicotinic Receptors: Underlying Mechanisms and Relevance to Nicotine Addiction // Biochemical Pharmacology. 2009. Vol. 78. P. 756–765.
Ware J. J. et al. From Men to Mice: CHRNA5/CHRNA3, Smoking Behavior and Disease // Nicotine &Tobacco Research. 2012.
Kaur-Knudsen D. et al. CHRNA3 Genotype, Nicotine Dependence, Lung Function and Disease in the General Population // European Respiratory Journal. 2012. Vol. 40.
P. 1538–1544.
Bierut L. J. et al. Variants in Nicotinic Receptors and Risk for Nicotine Dependence // The American Journal of Psychiatry. 2008. Vol. 165. P. 1163–1171.
Sherva R. et al. Association of a Single Nucleotide Polymorphism in Neuronal Acetylcholine Receptor Subunit Alpha 5 (CHRNA5) with Smoking Status and with ‘Pleasurable Buzz’ During Early Experimentation with Smoking // Addiction. September 2008. Vol. 103. No. 9. P. 1544–1552.
Janes A. C. et al. Association between CHRNA5 Genetic Variation at Rs16969968 and Brain Reactivity to Smoking Images in Nicotine Dependent Women // Drug and Alcohol Dependence. 1 January 2012. Vol. 120. No. 1–3. P. 7–13.
Li M. D. The Genetics of Nicotine Dependence // Current Psychiatry Reports. 2006. Vol. 8. P. 158–164.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5114a2.htm – оценка опасности курения от Министерства здравоохранения США.
Bornman M. S., du Plessis D. J. Smoking and Vascular Impotence. A Reason for Concern // South African Medical Journal. 13 September 1986. Vol. 70. No. 6. P. 329–30.
Mamede M. et al.Temporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study // Journal of Nuclear Medicine. 2007. Vol. 48. P. 1829–1835.
Taylor D. H. et al. Benefits of Smoking Cessation for Longevity // The American Journal of Pu blic Health. June 2002. Vol. 92. No. 6. P. 990–996.
Kendall S. B. Preference for Intermittent Reinforcement // Journal of the Experimental Analysis of Behavior. May 1974. Vol. 21. No. 3. P. 463–473.
Jorenby D. E. et al. Efficacy of Varenicline, an α4β Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation. A Randomized Controlled Trial // JAMA. 2006. Vol. 296. No. 1. P. 56–63.
Moore D. et al. Effectiveness and Safety of Nicotine Replacement Therapy Assist ed Reduction to Stop Smoking: Systematic Review and Meta-Analysis // British Medical Journal. 2009. Vol. 338.
Cornuz J. et al. A Vaccine Against Nicotine for Smoking Cessation: A Randomized Controlled Trial // PLoS ONE 3 (6): e2547.
Hicks M. J. et al. AAV – Directed Persistent Expression of a Gene Encoding Anti-Nicotine Antibody for Smoking Cessation // Science Translational Medicine. 27 June 2012.

Дата добавления: 2015-08-21